Podcasts

eClinical talks future of data management

eClinical talks future of data management

By Alexandria Pešić and Claire Videau

Clinical data management is, and will continue to be a key concern for the pharmaceutical industry, according to Susan Bornstein, executive vice president of eClinical solutions, who discussed the issue with Outsourcing-pharma earlier this week.

Regulatory expert insight: Regulatory information management

Industry view

Regulatory expert insight: Regulatory information management

By Gareth Macdonald

Tracking “non-content” metadata is an important part of any pharmaceutical submission, yet many drugmakers fail to take an integrated approach to the task according to regulatory expert Kate Wilber.

KCAS talks biomarker strategy development

KCAS talks biomarker strategy development

By Claire Videau and Gareth Macdonald

Biomarkers are critical to discovery and can help pharmaceutical firms make development a more efficient and cost effective process accord to bioanalysis services provider KCAS.

Almac Diagnostics discusses new biomarker service

Almac Diagnostics discusses new biomarker service

By Gareth Macdonald

Almac says an effective biomarker strategy boosts a drug candidates’ chance of success and can ultimately add value to a developer’s business by opening door to diagnostics.

Safety and value driving Phase IV growth at CROs; EVP

Safety and value driving Phase IV growth at CROs; EVP

By Gareth Macdonald

Increased focus on post-market safety and value has resulted in CROs handling more Phase IV work, according to a PharmaNet EVP, and this trend may continue as regulators seek real world evidence.

Follow us

Products

View more

Webinars